Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

NCT03103256 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension and Hyperlipidemia

Interventions

DRUG: YHP1701
DRUG: YHR1703
DRUG: YHR1704

Sponsor

Yuhan Corporation